Drug-loaded PLGA-mPEG microparticles as treatment for atopic dermatitis-like skin lesions in BALB/c mice model

References

• Al-Qadi S, Grenha A, Carrion-Recio D, Seijo B, Remunan-Lopez C. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: In vivo evaluation of insulin-loaded formulations. J Control Release, 2012;157:383–90
   PubMed Web of Science ®Google Scholar
• Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. PLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release, 2002;79:123–35
   PubMed Web of Science ®Google Scholar
• Bachert C, Maspero J. Efficacy of second-generation antihistamines in patients with allergic rhinitis and comorbid asthma. J Asthma, 2011;48:965–73
   PubMed Web of Science ®Google Scholar
• Bachert C, Vovolis V, Margari P, Murrieta-Aguttes M, Santoni JP. Mizolastine in the treatment of seasonal allergic rhinoconjunctivitis: A European clinical experience with 5408 patients managed in daily practice (PANEOS SAR Study). Allergy, 2001;56:653–9
   PubMed Web of Science ®Google Scholar
• Barzegar C, Pradalier A. Therapeutic approach to atopic dermatitis. Revue Francaise D Allergologie Et D Immunologie Clinique, 2002;42:410–24
   Google Scholar
• Belloni B, Ziai M, Lim A, Lemercier B, Sbornik M, Weidinger S, Andres C, Schnopp C, Ring J, Hein R, et al. Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels. J Allergy Clin Immunol, 2011;120:1223–5
   Google Scholar
• Bjorses K, Faxalv L, Montan C, Wildt-Persson K, Fyhr P, Holst J, Lindahl TL. In vitro and in vivo evaluation of chemically modified degradable starch microspheres for topical haemostasis. Acta Biomater, 2011;7:2558–65
   PubMed Web of Science ®Google Scholar
• Boguniewicz M, Eichenfield LF, Hultsch T. Current management of atopic dermatitis and interruption of the atopic march. J Allergy Clin Immunol, 2003;112:S140–50
   PubMedGoogle Scholar
• Boguniewicz M, Leung DY. 10. Atopic dermatitis. J Allergy Clin Immunol, 2006;117:S475–80
   PubMed Web of Science ®Google Scholar
• Dibildox J. Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials. J Allergy Clin Immunol, 2001;108:S54–8
   PubMed Web of Science ®Google Scholar
• Fujii Y, Takeuchi H, Sakuma S, Sengoku T, Takakura S. Characterization of a 2,4-dinitrochlorobenzene-induced chronic dermatitis model in rats. Skin Pharmacol Physiol, 2009;22:240–7
   PubMed Web of Science ®Google Scholar
• Fujimoto M, Oka T, Murata T, Hori M, Ozaki H. Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level. Eur J Pharmacol, 2009;602:432–8
   PubMed Web of Science ®Google Scholar
• Hazekawa M, Sakai Y, Yoshida M, Haraguchi T, Uchida T. The effect of treatment with a sustained-release prostacyclin analogue (ONO-1301-loaded PLGA microsphere) on short-term memory impairment in rats with transient global cerebral ischemia. J Microencapsul, 2012;29:211–18
   PubMed Web of Science ®Google Scholar
• Hernan Perez de la Ossa D, Ligresti A, Gil-Alegre ME, Aberturas MR, Molpeceres J, Di Marzo V, Torres Suarez AI. Poly-epsilon-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy. J Control Release, 2012;161:927–32
   PubMed Web of Science ®Google Scholar
• Hochhaus G. Pharmacokinetic/pharmacodynamic profile of mometasone furoate nasal spray: Potential effects on clinical safety and efficacy. Clin Ther, 2008;30:1–13
   PubMed Web of Science ®Google Scholar
• Inagaki N, Shiraishi N, Igeta K, Itoh T, Chikumoto T, Nagao M, Kim JF, Nagai H. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone. Eur J Pharmacol, 2006;546:189–96
   PubMed Web of Science ®Google Scholar
• Jay SM, Saltzman WM. Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking. J Control Release, 2009;134:26–34
   PubMed Web of Science ®Google Scholar
• Jhunjhunwala S, Balmert SC, Raimondi G, Dons E, Nichols EE, Thomson AW, Little SR. Controlled release formulations of IL-2, TGF-beta1 and rapamycin for the induction of regulatory T cells. J Control Release, 2012;159:78–84
   PubMed Web of Science ®Google Scholar
• Kang JS, Yoon WK, Han MH, Lee H, Lee CW, Lee KH, Han SB, Lee K, Yang KH, Park SK, Kim HM. Inhibition of atopic dermatitis by topical application of silymarin in NC/Nga mice. Int Immunopharmacol, 2008;8:1475–80
   PubMed Web of Science ®Google Scholar
• Karal-Yilmaz O, Serhatli M, Baysal K, Baysal BM. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(d,l-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique. J Microencapsul, 2011;28:46–54
   PubMed Web of Science ®Google Scholar
• Kim CH, Cheong KA, Park CD, Lee AY. Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC/Nga mice. Scand J Immunol, 2012;75:471–8
   PubMed Web of Science ®Google Scholar
• Koo J, Cuffie CA, Tanner DJ, Bressinck R, Cornell RC, DeVillez RL, Edwards L, Breneman DL, Piacquadio DJ, Guzzo CA, Monroe EW. Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: A multicenter study. Clin Ther, 1998;20:283–91
   PubMed Web of Science ®Google Scholar
• Lecaroz C, Gamazo C, Renedo MJ, Blanco-Prieto MJ. Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin. J Microencapsul, 2006;23:782–92
   PubMed Web of Science ®Google Scholar
• Lee JS, Feijen J. Biodegradable polymersomes as carriers and release systems for paclitaxel using Oregon Green(R) 488 labeled paclitaxel as a model compound. J Control Release, 2012;158:312–18
   PubMed Web of Science ®Google Scholar
• Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest, 2004;113:651–7
   PubMed Web of Science ®Google Scholar
• Leynadier F, Bousquet J, Murrieta M, Attali P. Efficacy and safety of mizolastine in seasonal allergic rhinitis. Ann Allergy Asthma Immunol, 1996;76:163–8
   PubMed Web of Science ®Google Scholar
• Li J, Jiang G, Ding F. Effects of polymer degradation on drug release from PLGA-mPEG microparticles: A dynamic study of microparticle morphological and physicochemical properties. J Appl Polym Sci, 2008a;108:2458–66
   Web of Science ®Google Scholar
• Li J, Jiang GQ, Ding FX. The effect of pH on the polymer degradation and drug release from PLGA-mPEG microparticles. J Appl Polym Sci, 2008b;109:475–82
   Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers, 2011;3:1377–97
   PubMed Web of Science ®Google Scholar
• Matsuoka H, Maki N, Yoshida S, Arai M, Wang J, Oikawa Y, Ikeda T, Hirota N, Nakagawa H, Ishii A. A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy, 2003;58:139–45
   PubMed Web of Science ®Google Scholar
• Na JH, Lee SY, Lee S, Koo H, Min KH, Jeong SY, Yuk SH, Kim K, Kwon IC. Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency. J Control Release, 2012;163:2–9
   PubMed Web of Science ®Google Scholar
• Nagai H, Hiyama H, Matsuo A, Ueda Y, Inagaki N, Kawada K. FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice. J Pharmacol Exp Ther, 1997;283:321–7
   PubMed Web of Science ®Google Scholar
• Park J, Fong PM, Lu J, Russell KS, Booth CJ, Saltzman WM, Fahmy TM. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. Nanomedicine, 2009;5:410–18
   PubMed Web of Science ®Google Scholar
• Patel B, Gupta V, Ahsan F. PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin. J Control Release, 2012;162:310–20
   PubMed Web of Science ®Google Scholar
• Pople PV, Singh KK. Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis-Part II: In vivo assessment of dermatopharmacokinetics, biodistribution and efficacy. Int J Pharm, 2012;434:70–9
   PubMed Web of Science ®Google Scholar
• Reis CP, Martinho N, Rosado C, Fernandes AS, Roberto A. Design of polymeric nanoparticles and its applications as drug delivery systems for acne treatment. Drug Dev Ind Pharm, 2014;40:409–17
   PubMed Web of Science ®Google Scholar
• Rosado C, Silva C, Reis CP. Hydrocortisone-loaded poly(epsilon-caprolactone) nanoparticles for atopic dermatitis treatment. Pharm Dev Technol, 2013;18:710–18
   PubMed Web of Science ®Google Scholar
• Rosca ID, Watari F, Uo M. Microparticle formation and its mechanism in single and double emulsion solvent evaporation. J Control Release, 2004;99:271–80
   PubMed Web of Science ®Google Scholar
• Samukawa K, Izumi Y, Shiota M, Nakao T, Osada-Oka M, Miura K, Iwao H. Red ginseng inhibits scratching behavior associated with atopic dermatitis in experimental animal models. J Pharmacol Sci, 2012;118:391–400
   PubMed Web of Science ®Google Scholar
• Terakawa M, Fujieda Y, Tomimori Y, Muto T, Tanaka T, Maruoka H, Nagahira K, Ogata A, Nakatsuka T, Fukuda Y. Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis. Eur J Pharmacol, 2008;601:186–91
   PubMed Web of Science ®Google Scholar
• Yang XZ, Dou S, Sun TM, Mao CQ, Wang HX, Wang J. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy. J Control Release, 2011;156:203–11
   PubMed Web of Science ®Google Scholar
• Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials, 2001;22:231–41
   PubMed Web of Science ®Google Scholar
• Yeh M, Chiang C. Inactive Vibrio cholerae whole-cell vaccine-loaded biodegradable microparticles: In vitro release and oral vaccination. J Microencapsul, 2004;21:91–106
   PubMed Web of Science ®Google Scholar
• Yuan XY, Ma HM, Li RZ, Wang RY, Liu W, Guo JY. Topical application of aloperine improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice. Eur J Pharmacol, 2011;658:263–9
   PubMed Web of Science ®Google Scholar
• Zou P, Suo J, Nie L, Feng S. Temperature-sensitive biodegradable mixed star-shaped block copolymers hydrogels for an injection application. Polymer, 2012;53:1245–57
   Web of Science ®Google Scholar